Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… & Infectious Diseases (ECCMID) 2023. Effectiveness, safety, and patterns of real-world isavuconazole use—a …
… OPPORTUNITY Our client wanted to measure real-world treatment patterns, healthcare resource use, HRQOL, and … and a cross-sectional patient survey The patient survey used a prospective 7-day patient diary to evaluate HRQOL and …
… timelines for the availability of data while adhering to project deadlines. Additionally, we needed to account for … to propose a cohesive set of core analyses that could be used as needed across the trials. This allowed for … estimate the average differences in HRQOL scores between treatment groups during follow-up while controlling for …
… availability of innovative health technologies across the EU. …
… Pharmacoepidemiology and Risk Management Women's Health Diabetes & Endocrine Disorders Telecommuter - Germany ScD, … She did her postdoctoral training at the Center for Drug Evaluation and Research in the United States Food and Drug … areas and has a special interest in pediatrics and drug safety in pregnancy. …
… Selecting a time horizon Identifying current and projected treatment mix Estimating current and future drug costs …
… in using secondary data to assess the utilization and safety of medications and vaccines, including … of therapeutic and disease areas, including cancer, type 2 diabetes, multiple sclerosis, and vaccines, with substantial … the Sentinel Program and the Vaccine Safety Datalink Project, two federally-funded postmarket safety surveillance …
… through publication planning, publication development, and project management. Let our team be your partner in … We develop a customized timeline for every publication project to meet your deadlines and complement your overall …
… 12, 2022 Most of what we know about treatments, adverse events, and the overall survival of patients with chronic … fully. To provide detailed information about different treatment types for CLL and MCL in routine clinical settings, … can affect patients’ health outcomes (such as adverse events and survival) and financial outcomes (direct medical …
… health condition, treatments you may have received, or safety and health information in relation to client products … Personal Data that we collect about you will be recorded, used, and protected by RTI-HS and its vendors in accordance … as necessary and appropriate for the specific research project. Prior to any data collection, the consent of the …